PharmaMar files for FDA approval of small cell lung cancer drug

PharmaMar files for FDA approval of small cell lung cancer drug

Submitted by admin on December 17, 2019 - 10:37am
Source: 
Fierce Biotech
News Tags: 
PharmaMar
FDA
lurbinectedin
small cell lung cancer
Headline: 
PharmaMar files for FDA approval of small cell lung cancer drug
snippet: 

PharmaMar has filed for FDA approval of lurbinectedin in relapsed small cell lung cancer. The filing tees PharmaMar up to become the first company to win approval for a new chemical entity in the disease in more than 20 years.

Do Not Allow Advertisers to Use My Personal information